Abstract
Previous studies have shown spinal cord stimulation (SCS) to be cost-effective in comparison to conventional medical management (CMM) in persistent back and leg pain following spine surgery (1), but this has not been studied in patients with chronic neuropathic and refractory back pain who do not respond to CMM and have no history of and are not good candidates for spine surgery, a condition we term non-surgical refractory back pain (NSRBP). This is the first randomized controlled study (RCT) to prospectively gather health care utilization (HCU) information in the NSRBP population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
